General information - Eureko Sigorta
General information - Eureko Sigorta
General information - Eureko Sigorta
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
62 EUREKO S‹GORTA<br />
EUREKO S‹GORTA A.fi.<br />
Notes to the Financial Statements As at 31 December 2008<br />
(Currency: New Turkish Lira (TRY))<br />
2.30 New standards and interpretations not yet adopted (continued)<br />
• The amendments to TFRS 1 – First-time Adoption of Turkish Financial Reporting Standards and TAS 27 – Consolidated<br />
and Separate Financial Statements respond to constituents’ concerns that retrospectively determining cost and applying<br />
the cost method in accordance with TAS 27 on first-time adoption of TFRSs cannot, in some circumstances, be achieved<br />
without undue cost or effort. The amendments address that issue:<br />
- by allowing first-time adopters to use a deemed cost of either fair value or the carrying amount under previous<br />
accounting practice to measure the initial cost of investments in subsidiaries, jointly controlled entities and associates<br />
in the separate financial statements; and<br />
- by removing the definition of the cost method from TAS 27 and replacing it with a requirement to present dividends<br />
as income in the separate financial statements of the investor.<br />
The amendments to TAS 27 also respond to queries regarding the initial measurement of cost in the separate financial<br />
statements of a new parent formed as the result of a specific type of reorganisation. The amendments require the new<br />
parent to measure the cost of its investment in the previous parent at the carrying amount of its share of the equity items<br />
of the previous parent at the date of the reorganisation.<br />
The amendment, effective for annual periods beginning on or after 1 January 2009, is not expected to have any impact<br />
on the financial statements of the Company.<br />
• The amendments to TAS 28 – Investments in Associates (and consequential amendments to TAS 32 – Financial<br />
Instruments: Presentation, and TFRS 7 – Financial Instruments: Disclosures) clarify that after applying the equity method,<br />
any additional impairment recognized by the investor with respect to its investment in an associate should not be<br />
allocated to any assets, including goodwill, that constitute the carrying amount of the investment. The amendments<br />
also clarify that reversals of impairment are recorded as an adjustment to the investment balance to the extent that<br />
the recoverable amount of the associate increases. The amendment is effective for annual periods beginning on or<br />
after 1 January 2009, although entities are permitted to adopt them earlier, is not expected to have any impact on<br />
the financial statements of the Company.<br />
• In accordance with the amendments to TAS 27 – Consolidated and Separate Financial Statements, TAS 39 – Financial<br />
Instruments: Recognition and Measurement would continue to be applied where an investment in a subsidiary that<br />
is accounted for under TAS 39, is classified as held for sale under TFRS 5 – Non-Current Assets Held-for-Sale and<br />
Discontinued Operations. The amendment, effective for annual periods beginning on or after 1 January 2009, is not<br />
expected to have any impact on the financial statements of the Company.<br />
• The amendments to TAS 28 – Investments in Associates (and consequential amendments to TAS 32 – Financial<br />
Instruments: Presentation and TFRS 7 – Financial Instruments: Disclosures requires that only certain rather than all<br />
disclosure requirements in TAS 28 need to be made in addition to disclosures required by TAS 32 and TFRS 7, where<br />
an investment in associate is accounted for in accordance with TAS 39 – Financial Instruments: Recognition and<br />
Measurement. The amendment, effective for annual periods beginning on or after 1 January 2009, is not expected<br />
to have any impact on the financial statements of the Company.<br />
• The amendments to TAS 31 – Interests in Joint Ventures (and consequential amendments to TAS 32 – Financial<br />
Instruments: Presentation and TFRS 7 – Financial Instruments: Disclosures requires that only certain rather than all<br />
disclosure requirements in TAS 31 need to be made in addition to disclosures required by TAS 32 and TFRS 7, where<br />
an investment in associate is accounted for in accordance with TAS 39 – Financial Instruments: Recognition and<br />
Measurement. The amendment, effective for annual periods beginning on or after 1 January 2009, is not expected<br />
to have any impact on the financial statements of the Company.